Top 3 Health Care Stocks That Are Set To Fly This Quarter
Portfolio Pulse from Avi Kapoor
The article highlights three oversold health care stocks with RSI values near or below 30, indicating potential buying opportunities. The stocks mentioned are Haemonetics Corporation (NYSE:HAE), ImmunityBio Inc (NASDAQ:IBRX), and Progyny Inc (NASDAQ:PGNY).
August 16, 2024 | 11:57 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Haemonetics Corporation posted better-than-expected quarterly earnings but saw its stock fall around 19% over the past month. The RSI value is 25.47, indicating it is oversold.
Despite strong earnings, the stock's significant decline and low RSI suggest it is oversold, presenting a potential buying opportunity.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
ImmunityBio announced a study on a new cancer therapy but saw its stock fall around 38% over the past month. The RSI value is 29.87, indicating it is oversold.
The announcement of a new cancer therapy study is positive, but the stock's significant decline and low RSI suggest it is oversold, presenting a potential buying opportunity.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Progyny reported worse-than-expected Q2 revenue results, leading to a 31% decline in stock price over the past month. The RSI value is 29.06, indicating it is oversold.
Despite weak Q2 revenue results, the stock's significant decline and low RSI suggest it is oversold, presenting a potential buying opportunity.
CONFIDENCE 88
IMPORTANCE 75
RELEVANCE 100